These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34686782)

  • 1. Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.
    Khan S; Pati S; Singh S; Akhtar M; Khare P; Khan S; Shafi S; Najmi AK
    Int J Obes (Lond); 2022 Feb; 46(2):245-254. PubMed ID: 34686782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Role of WNT Signaling in Metabolic Syndrome-Linked Alzheimer's Disease.
    Ali A; Ali A; Ahmad W; Ahmad N; Khan S; Nuruddin SM; Husain I
    Mol Neurobiol; 2020 Jan; 57(1):302-314. PubMed ID: 31325024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease.
    Pugazhenthi S
    Prog Mol Biol Transl Sci; 2017; 146():243-258. PubMed ID: 28253987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.
    Kim B; Feldman EL
    Exp Mol Med; 2015 Mar; 47(3):e149. PubMed ID: 25766618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation.
    Al-Kuraishy HM; Jabir MS; Albuhadily AK; Al-Gareeb AI; Rafeeq MF
    Ageing Res Rev; 2023 Nov; 91():102084. PubMed ID: 37802319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?
    Campos-Peña V; Toral-Rios D; Becerril-Pérez F; Sánchez-Torres C; Delgado-Namorado Y; Torres-Ossorio E; Franco-Bocanegra D; Carvajal K
    Antioxid Redox Signal; 2017 Apr; 26(10):542-560. PubMed ID: 27368351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model.
    Tyagi A; Mirita C; Taher N; Shah I; Moeller E; Tyagi A; Chong T; Pugazhenthi S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165849. PubMed ID: 32485218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitate and glucose increase amyloid precursor protein in extracellular vesicles: Missing link between metabolic syndrome and Alzheimer's disease.
    Kim B; Kang YT; Mendelson FE; Hayes JM; Savelieff MG; Nagrath S; Feldman EL
    J Extracell Vesicles; 2023 Nov; 12(11):e12340. PubMed ID: 37898562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome.
    Hishikawa N; Fukui Y; Sato K; Kono S; Yamashita T; Ohta Y; Deguchi K; Abe K
    Eur J Neurol; 2016 Feb; 23(2):339-45. PubMed ID: 26493280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration.
    Więckowska-Gacek A; Mietelska-Porowska A; Wydrych M; Wojda U
    Ageing Res Rev; 2021 Sep; 70():101397. PubMed ID: 34214643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis.
    Zuin M; Roncon L; Passaro A; Cervellati C; Zuliani G
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2244-2252. PubMed ID: 34039508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.
    Watts AS; Loskutova N; Burns JM; Johnson DK
    J Alzheimers Dis; 2013; 35(2):253-65. PubMed ID: 23388170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity.
    Misiak B; Leszek J; Kiejna A
    Brain Res Bull; 2012 Nov; 89(3-4):144-9. PubMed ID: 22921944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
    Luchsinger JA; Zetterberg H
    Int Rev Neurobiol; 2020; 154():51-77. PubMed ID: 32739014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism.
    Arshad N'; Lin TS; Yahaya MF
    CNS Neurol Disord Drug Targets; 2018; 17(8):595-603. PubMed ID: 30047340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The link between iron, metabolic syndrome, and Alzheimer's disease.
    Grünblatt E; Bartl J; Riederer P
    J Neural Transm (Vienna); 2011 Mar; 118(3):371-9. PubMed ID: 20556444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.